XBiotech Inc.
XBIT
$7.87
-$0.34-4.14%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 300.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 300.00K |
| Cost of Revenue | -- | -- | -- | -- | 16.00K |
| Gross Profit | -- | -- | -- | -- | 284.00K |
| SG&A Expenses | 783.00K | 973.00K | 1.99M | 915.00K | 1.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.59M | 8.52M | 13.26M | 7.15M | 8.46M |
| Operating Income | -8.59M | -8.52M | -13.26M | -7.15M | -8.16M |
| Income Before Tax | -4.73M | -7.06M | -8.67M | -3.85M | -2.63M |
| Income Tax Expenses | -99.00K | 308.00K | 71.00K | -37.00K | 578.00K |
| Earnings from Continuing Operations | -4.64M | -7.36M | -8.74M | -3.82M | -3.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.64M | -7.36M | -8.74M | -3.82M | -3.20M |
| EBIT | -8.59M | -8.52M | -13.26M | -7.15M | -8.16M |
| EBITDA | -8.15M | -8.09M | -12.82M | -6.70M | -7.72M |
| EPS Basic | -0.15 | -0.24 | -0.29 | -0.13 | -0.11 |
| Normalized Basic EPS | -0.10 | -0.14 | -0.18 | -0.08 | -0.05 |
| EPS Diluted | -0.16 | -0.24 | -0.29 | -0.13 | -0.11 |
| Normalized Diluted EPS | -0.10 | -0.14 | -0.18 | -0.08 | -0.05 |
| Average Basic Shares Outstanding | 30.44M | 30.44M | 30.44M | 30.44M | 30.44M |
| Average Diluted Shares Outstanding | 30.44M | 30.44M | 30.44M | 30.44M | 30.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
